INTERNATIONAL PATENT: BETA PHARMA, INC. FILES APPLICATION FOR "ESTROGEN RECEPTOR DEGRADERS AS TREATMENTS FOR BREAST CANCER"

GENEVA, Nov. 25 -- BETA PHARMA, INC. (1000 N. West StreetSuite 1200Wilmington, Delaware 19801) filed a patent application (PCT/US2025/028616) for "ESTROGEN RECEPTOR DEGRADERS AS TREATMENTS FOR BREAST CANCER" on May 09, 2025. With publication no. WO/2025/240252, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Don (1000 N. West StreetSuite 1200Wilmington, Delaware 19801), PENG, Jirong (1000 N. West StreetSuite 1200Wilmington, Delaware 19801), GREEN, Michael Alan (1000 N. West StreetSuite 1200Wilmington, Delaware 1980...